Abundance Wealth Counselors Raises Position in Mettler-Toledo International, Inc. $MTD

Abundance Wealth Counselors increased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 2.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 753 shares of the medical instruments supplier’s stock after purchasing an additional 17 shares during the quarter. Abundance Wealth Counselors’ holdings in Mettler-Toledo International were worth $896,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. raised its position in Mettler-Toledo International by 7.7% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,680 shares of the medical instruments supplier’s stock worth $3,148,000 after purchasing an additional 192 shares during the period. Robeco Institutional Asset Management B.V. raised its position in Mettler-Toledo International by 83.0% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 69,973 shares of the medical instruments supplier’s stock worth $82,199,000 after purchasing an additional 31,736 shares during the period. Pacific Point Advisors LLC raised its position in Mettler-Toledo International by 7.3% in the 2nd quarter. Pacific Point Advisors LLC now owns 1,151 shares of the medical instruments supplier’s stock worth $1,352,000 after purchasing an additional 78 shares during the period. V Square Quantitative Management LLC raised its position in Mettler-Toledo International by 3.7% in the 2nd quarter. V Square Quantitative Management LLC now owns 559 shares of the medical instruments supplier’s stock worth $657,000 after purchasing an additional 20 shares during the period. Finally, Sound Income Strategies LLC raised its position in Mettler-Toledo International by 477.8% in the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 43 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Activity

In other news, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the sale, the insider owned 94 shares of the company’s stock, valued at approximately $123,012.16. The trade was a 63.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director directly owned 283 shares of the company’s stock, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,827 shares of company stock valued at $2,371,208. Corporate insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on MTD shares. Evercore ISI decreased their target price on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research report on Monday, August 4th. Robert W. Baird raised their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Barclays raised their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a report on Thursday. Bank of America raised their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday, September 22nd. Finally, Citigroup raised their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a report on Thursday, August 21st. Five investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $1,328.33.

Mettler-Toledo International Trading Up 0.9%

Shares of MTD opened at $1,301.49 on Friday. The firm’s 50-day moving average price is $1,271.22 and its 200-day moving average price is $1,185.85. The firm has a market capitalization of $26.81 billion, a price-to-earnings ratio of 32.96, a PEG ratio of 3.87 and a beta of 1.37. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,488.75.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.